Box 1. RetroNectin treatment for colocalization of virus and target cells

From the following article

Use of a lentivirus/VSV pseudotype virus for highly efficient genetic redirection of human peripheral blood lymphocytes

Anthony Simmons and Kristina Jantz

Nature Protocols 1, 2688 - 2700 (2007)

doi:10.1038/nprot.2006.409

BACK TO ARTICLE

RetroNectin may be used to facilitate colocalization of virus and target cells. This is particularly important for retrovirus transduction9 but can generally be omitted when using Lentivirus/VSV pseudotyped virus. It is included here should readers elect to use retroviruses for rapidly dividing cell targets.

Infection of PBLs:

  1. On Day 3 after lymphocye stimulation with anti-CD3 and anti-CD28, coat a 24-well plate with 1 ml per well of RetroNectin (12 mug ml-1).
  2. Incubate at 4 °C overnight.
  3. On Day 4 after lymphocyte stimulation, remove the RetroNectin and wash with PBS once.
  4. Block plate with 1% BSA in PBS at 37 °C for 20 min.
  5. Remove BSA and wash once with PBS.
  6. To each well add 0.5-1 times 106 lymphocytes per ml in 2.8 ml of filtered PT67 supernatant.
  7. Culture for 4 d at 37 °C in a 5% CO2 atmosphere.
  8. Remove supernatant from log-phase PT67 packaging cells infected with GFP-chTCR retroviral vector.
  9. Pass supernatant through a 0.45 m filter.
  10. Incubate the culture at 37 °C for 5 h; gently remove viral supernatant.
  11. Replace with RPMI-GM containing 50 mu ml-1 of IL-2.
  12. Repeat the transduction procedure next day.
  13. Harvest lymphocytes after 2 d by vigorous flushing and washing of the wells.
  14. Resuspend cells in RPMI-GM containing 50 U ml-1 IL-2 and incubate in a 5% CO2 atmosphere at 37 °C.
  15. Add additional IL-2 (50 U ml-1) every other day.
  16. After 2–4 d, begin analyzing the cells daily for GFP expression using an inverted fluorescence microscope.